Author Correction: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial

Affiliations

• ¹ Neuroscape, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA. [email protected].
• ² Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, USA. [email protected].
• ³ Department of Veterans Affairs, Research Service, San Francisco VA Medical Center, San Francisco, CA, USA. [email protected].
• ⁴ Aguazul-Bluewater, Inc., Boulder, CO, USA.
• ⁵ Boston University School of Medicine, Boston, MA, USA.
• ⁶ Wholeness Center, Fort Collins, CO, USA.
• ⁷ Department of Psychiatry, New York University Grossman School of Medicine, New York, NY, USA.
• ⁸ Zen Therapeutic Solutions, Mt. Pleasant, SC, USA.
• ⁹ Nautilus Sanctuary, New York, NY, USA.
• ¹⁰ Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
• ¹¹ Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, USA.
• ¹² San Francisco Insight and Integration Center, San Francisco, CA, USA.
• ¹³ New School Research, LLC, Los Angeles, CA, USA.
• ¹⁴ MAPS Public Benefit Corporation, San Jose, CA, USA.
• ¹⁵ Medical University of South Carolina, Charleston, SC, USA.
• ¹⁶ Kleiman Consulting and Psychological Services, PC, Ivyland, PA, USA.
• ¹⁷ KPG Psychological Services, LLC, Brunswick, ME, USA.
• ¹⁸ University of Haifa, Haifa, Israel.
• ¹⁹ MAPS Israel, Hod Hasharon, Israel.
• ²⁰ Tulip Medical Consulting, LLC, Port Townsend, WA, USA.
• ²¹ Multidisciplinary Association for Psychedelic Studies (MAPS), San Jose, CA, USA.